On June 1, 2022 Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, reported that management will participate in two upcoming investor conferences in June (Press release, Wugen, JUN 1, 2022, View Source [SID1234615351]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Healthcare Conference
Format: Presentation
Presentation Date/Time: Wednesday, June 8, 2022 at 4:30 p.m. ET
Location: New York City

2022 Truist Securities Symposia
Format: Panel titled "Novel Engineered NK Cell Therapies: Pursuit of The Right Phenotype"
Presentation Date/Time: Tuesday, June 28, 2022 at 11:00 a.m. ET
Location: New York City